Stoke Therapeutics, Inc.
STOK
35 insider filings · Latest: Aug 3, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Aug 3, 2026 | Aug 5 8:17 PM | Barry TichoCHIEF MEDICAL OFFICER | Sale | 7,176 | $29.04 | $208.4K | 20,422(D) | View → |
| Aug 3, 2026 | Aug 3 8:48 PM | BARUCH TICHO | Proposed Sale | 20,967 | $28.86 | $605.1K | — | View → |
| Jul 1, 2026 | Jul 6 8:10 PM | Barry TichoCHIEF MEDICAL OFFICER | Sale | 7,228 | $32.66 | $236.1K | 27,598(D) | View → |
| Jul 1, 2026 | Jul 1 8:51 PM | BARUCH S. TICHO | Proposed Sale | 7,228 | $32.72 | $236.5K | — | View → |
| Jun 16, 2026 | Jun 18 8:18 PM | Jonathan AllanGENERAL COUNSEL & CORP SEC | Sale | 1,457 | $29.95 | $43.6K | 18,086(D) | View → |
| Jun 16, 2026 | Jun 16 8:33 PM | JONATHAN D ALLAN | Proposed Sale | 1,457 | $30.00 | $43.7K | — | View → |
| Jun 1, 2026 | Jun 3 9:33 PM | Barry TichoCHIEF MEDICAL OFFICER | Sale | 1,795 | $30.58 | $54.9K | 34,826(D) | View → |
| May 1, 2026 | May 5 8:18 PM | Barry TichoCHIEF MEDICAL OFFICER | Sale | 2,243 | $32.79 | $73.5K | 36,621(D) | View → |
| May 1, 2026 | May 1 8:44 PM | BARUCH S. TICHO | Proposed Sale | 4,038 | $32.72 | $132.1K | — | View → |
| Apr 1, 2026 | Apr 3 8:12 PM | Barry TichoCHIEF MEDICAL OFFICER | Sale | 1,838 | $32.66 | $60.0K | 38,864(D) | View → |
| Apr 1, 2026 | Apr 1 8:39 PM | BARUCH S. TICHO | Proposed Sale | 1,838 | $32.56 | $59.8K | — | View → |
| Mar 20, 2026 | Mar 24 8:19 PM | Jonathan AllanGENERAL COUNSEL & CORP SEC | Sale | 9,293 | $33.69 | $313.0K | 19,543(D) | View → |
| Mar 20, 2026 | Mar 20 8:33 PM | JONATHAN ALLAN | Proposed Sale | 9,293 | $33.19 | $308.4K | — | View → |
| Mar 19, 2026 | Mar 19 10:01 PM | Barry TichoCHIEF MEDICAL OFFICER | Sale | 1,461 | $29.99 | $43.8K | 40,702(D) | View → |
| Mar 18, 2026 | Mar 19 10:01 PM | Barry TichoCHIEF MEDICAL OFFICER | Sale | 6,686 | $31.34 | $209.6K | 40,798(D) | View → |
| Mar 17, 2026 | Mar 19 10:01 PM | Barry TichoCHIEF MEDICAL OFFICER | Sale | 6,164 | $33.01 | $203.5K | 47,484(D) | View → |
| Mar 18, 2026 | Mar 19 10:00 PM | Thomas LeggettChief Financial Officer | Sale | 2,382 | $31.34 | $74.7K | 10,172(D) | View → |
| Mar 17, 2026 | Mar 19 10:00 PM | Thomas LeggettChief Financial Officer | Sale | 2,196 | $33.01 | $72.5K | 12,554(D) | View → |
| Mar 18, 2026 | Mar 19 9:58 PM | Jason HoittChief Patient Officer | Sale | 1,931 | $31.34 | $60.5K | 10,276(D) | View → |
| Mar 17, 2026 | Mar 19 9:58 PM | Jason HoittChief Patient Officer | Sale | 1,781 | $33.01 | $58.8K | 12,207(D) | View → |
Page 1 of 3
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Feb 17, 2026 | Feb 19 9:22 PM | Thomas LeggettChief Financial Officer | Grant/Award | 100,000 | $31.09 | 40,000(D) | View → |
| Feb 17, 2026 | Feb 19 9:21 PM | Jason HoittChief Patient Officer | Grant/Award | 120,000 | $31.09 | 48,000(D) | View → |
| Feb 17, 2026 | Feb 19 9:20 PM | Jonathan AllanGENERAL COUNSEL & CORP SEC | Grant/Award | 88,000 | $31.09 | 35,000(D) | View → |
← Previous
Page 2 of 2